Effect of Umo Concentrated Solution on Promotion of Hyaluronic Acid Production in Dermal Fibroblasts   Exam number: CAS19020503 Test Report Client :  APA Corporation Co., Ltd. Test Substance :  Umo Concentrated Solution Test Item :  Promotion of hyaluronic acid production in dermal fibroblasts Test Date :  February 5, 2019 Storage Period :  5 years after test completion t   Report Structure 1 Summary 2 Test purpose 3 Exam overview 4 Materials and test methods 4-1 cells 4-

Evaluation of Elastase Inhibitory Activity Test Report Test Product :  UMO Concentrated Solution Test Requester :  APA Corporation Test Item :  Elastase Inhibitory Activity Evaluation Retention Period :  5 years after test completion Report Structure Summary Test Objective Test Overview Materials and Methods 4.1 Test Material 4.2 Test Procedure 4.2.1 Elastase Inhibitory Activity Test Results 5.1 Elastase Inhibitory Activity References 1. Summary The addition of UMO

Test Number: OSA19020702 Evaluation of the Effect of UMO Concentrated Solution on Expression Wrinkles Test requester APA Corporation 60-11 Tokuhara, Ishii-cho, Anjo City, Aichi 444-1201, Japan Test Contractor & Test Facility Kirei Test Lab Co., Ltd.2-11-6 Tomioka, Koto-ku, Haseban Building 3F, Tokyo 135-0047, Japan Summary The two-dimensional replica analysis  of wrinkle area showed that after application of the test product, the relative wrinkle area was significantly lower

Measurement of Transepidermal Water Loss (TEWL) Before and After Application Test Number:  CSA190207 Summary The effect of UMO Concentrated Solution  on transepidermal water loss (TEWL) was evaluated to verify its immediate effect on skin barrier function. The TEWL at the site where the test product was applied was significantly lower  than the control site 1 hour after application . These results suggest that UMO Concentrated Solution  has an immediate beneficial effect on t

Inspection, Testing, and Evaluation Results Report September 7, 2020 To: APA Corporation Co., Ltd. From: Consumer Science Research Institute Co., Ltd. 20F, Edobori Center Building2-1-1 Edobori, Nishi-ku, Osaka 550-0002, Japan TEL: (06) 6445-4670 FAX: (06) 6445-4671 We hereby report the inspection, testing, and evaluation results of the submitted samples received on March 5, 2020. Approved by / Test Supervisor:   Asano Nakagawa 1. Test Samples Three (3) shampoo products (see P

Test Report Immediate Effects of UMO Silica Micron Powder on Skin Moisturization and Firmness/Elasticity Commissioning Company: APA Corporation Co., Ltd. Test Product: Micron Powder(All ingredients of the test product and the model facial cleanser are listed in Appendix 1) Test Items: Moisturization and firmness/elasticity (immediate effects) Measurement of stratum corneum moisture content Measurement of skin viscoelasticity Test Date: April 2, 2020 Data Retention Period: 5 y

Test Report Tyrosinase and Elastase Inhibitory Activities of UMO Micron Powder Evaluation Client : APA Corporation Co., Ltd. Test Material : UMO Micron Powder Test Items : Cosmetic 3-Area Screening Set 〈Skin Whitening · Anti-aging · Antioxidant〉 Tyrosinase inhibitory activity Elastase inhibitory activity Test Date : March 16, 2020 Data Retention Period : 5 years after completion of the test Report Structure Summary Test Obje

Effect of GLM Concentrated Solution on Anti-Ageing Related Gene Expression (Using the Real-Time PCR Method) Requesting Company :  APA Corporation Test Substance :  GLM Concentrated Solution Test Item :  Analysis of effects on anti-aging related gene expression Test Date :  August 20, 2019 Storage Period :  5 years after test completion 1. Summary When GLM concentrated solution was added to cultured human dermal cells: The gene expression of Hyaluronan Synthase 1 (HAS1)

Virus Inactivation Test – Test Report – 1. Title Virus Inactivation Test 2. Test Number 207636N 3. Purpose The test was conducted to evaluate the effect of the test substance, GLM concentrated solution, on feline calicivirus. 4. Test Substance GLM Concentrated Solution 5. Test Microorganism Feline Calicivirus (FCV), F-9 strain The virus was pre-cultured in CRFK cells and then diluted 10-fold with sterilized phosphate-buffered saline (PBS) to prepare the test virus solution. 6